Key result
Anticoagulation, HF therapy, and PCI reduce thrombus size ~67% and stabilize clinical status.
Why the study?
Accurate identification and management of cardiac thrombi in young patients with drug-induced dilated cardiomyopathy and thrombophilia are critical but not well characterized.
Case Report (n=1)
This case highlights the importance of evaluating for inherited thrombophilia in young patients with intracardiac thrombus and demonstrates the efficacy of combined anticoagulation and interventional therapies.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to atypical thrombi in young substance users; leaves open standardized diagnostic and management protocols.
Introduction Cardiac thrombi are often incidental findings on cardiac imaging and typically appear as uniform echo-densities. They develop in areas of blood flow stasis, particularly in structurally abnormal chambers such as in dilated cardiomyopathy. Their differential diagnosis includes vegetations and tumors, therefore accurate identification is critical for appropriate management. Case Presentation We present the case of a 27-year-old male patient with a history of smoking and drug use, admitted for dyspnea and fatigue. Echocardiography revealed globally dilated chambers with severe apical hypokinesia and a large echogenic mass in the left ventricle. Laboratory investigations showed elevated hs-cTnI, NT-proBNP, and D-dimer levels. Coronary angiography demonstrated a subocclusive stenosis in the left anterior descending artery, likely from a partially recanalized thrombus, and was treated with angioplasty and drug-eluting stent placement. The thrombophilia panel revealed minor thrombophilia: MTHFR A1298C (homozygous), EPCR (A1/A2 Allele), Factor XIII and PAI-1 (heterozygous). The patient was managed conservatively with anticoagulation, heart failure therapy, and percutaneous coronary intervention. Follow-up showed a two-thirds reduction in thrombus size and stable status. Conclusions This case highlights the importance of considering inherited thrombophilia in young patients presenting with intracardiac thrombus. For favorable outcomes, assessment of underlying thrombophilia, a combination of appropriate anticoagulation and interventional therapies are essential.
No takes yet. Share an insight, caveat, or question.
Grigoroaea et al. (2025) conducted a case report in Coronary embolism and massive intraventricular thrombus (n=1). Anticoagulation, heart failure therapy, and percutaneous coronary intervention was evaluated on Thrombus size and clinical status. Management with anticoagulation, heart failure therapy, and percutaneous coronary intervention resulted in a two-thirds reduction in thrombus size and stable clinical status.
Synapse has enriched 10 related papers. Consider them for comparative context: